September $100K Match Means Double Your Impact

September is Prostate Cancer Awareness Month, and for patients, survivors, caregivers and loved ones, this is YOUR month. Together, with our inspiring community, we are raising awareness and helping to save lives all across the nation.

Big news is the announcement of our largest match to date this year for the month of September – $100,000! That means, when you donate, your gift is doubled – helping more men and their families battle this disease. With the ongoing impacts of the COVID-19 pandemic causing many hardships for prostate cancer patients and their families, your help is needed more than ever. You can donate right now.

Remember, early detection saves lives and that’s exactly what Prostate Cancer Awareness Month is about. Thank you for being part of our caring community. Let’s ZERO out prostate cancer together!

Breaking News: ZERO Cancer Day is on September 18

A highlight of our Prostate Cancer Awareness Month is ZERO Cancer Day! This special day showcases and celebrates the impact of our generous donors to make support programs, education, and research reach patients and their families. Helping patients is directly made possible by your donations. Expect some surprises and breaking news from ZERO. Join us Saturday, September 18th for ZERO Cancer Day on our Facebook page, or stream our announcements at Noon, 7:00 PM, and 9:00 PM (ET) by visiting zerocancer.live/pcam.

September Run/Walks Go from In-Person to Virtual

Our 2021 ZERO Prostate Cancer Run/Walk Series has begun and is hitting its stride. All across the country, people are signing up, forming teams, and fundraising…and we thank you. We do want to make you aware that under the guidance of ZERO’s Medical Advisory Board with the vision to keep prostate cancer patients and their families safe, we are transitioning all September In-person Run/Walks to Virtual Events.

They will now be held through the Charge Running App, where you’ll be able to run/walk together at the same time on whatever course you choose. You’ll hear live inspirational coaching and music along the way, have access to the app chat feature to connect with other participants, and see a live leaderboard of results. Watch this quick video on the Charge App to learn more. If you don’t see a Run/Walk city near you – join our National Virtual Run/Walk to be part of our nationwide movement!

Next Episode Released in our Jay Jay French Podcast Series

When it comes to prostate cancer, We’re Not Gonna Take It! That’s why we’ve partnered with Twisted Sister’s Jay Jay French again this month. We’ve got another Prostate Cancer Uncensored podcast to share, as well as a special ZERO Cancer Day surprise. Don’t forget to test your prostate cancer knowledge by taking Jay Jay’s Truth or Twisted quiz.

Registration is Open for the 2022 ZERO Summit

When you come to the ZERO Prostate Cancer Summit, you’ll meet a #ZEROStrong community of people who understand what you’re going through: men and women who’ve faced what you faced and are here to support you in your journey. The 2022 ZERO Summit will be a hybrid event that offers two ways to attend. Whether you join us in-person or virtually, you’ll hear from the top minds in medicine, research, education, and advocacy.

Register today to be among the first to see what’s on the cutting edge of research, learn the latest about living with and caring for those who have prostate cancer, and see the difference that passionate advocacy can make in the lives of patients and their families!

Join ZERO’s Racial Disparities Town Hall

One of the biggest challenges when it comes to ending prostate cancer is that Black men are nearly twice as likely to be diagnosed and die from the disease. Addressing and ultimately eliminating racial disparities in prostate cancer is critical. Join us at a Racial Disparities Town Hall on September 30 at 10:00 AM ET. Bring your questions and thoughts to share with members of ZERO’s Racial Disparities Task Force and our new Vice President of Health Equity, Dr. Reggie Tucker-Seeley.

Attention Veterans: Share Your Experience

To better serve the veteran community, ZERO has created a Veterans and Prostate Cancer Survey. Veterans are a high-risk group for prostate cancer with an incidence rate that is twice that of the general population. Help us serve those who served us, by completing this survey if you are a vet, or by sharing with all of the veterans in your life.

Participate in Research and Give Back

Prostate cancer research transforms and saves lives. Will you consider participating in a clinical and research study to help do just that? You may be asked to share your story or complete a survey, join a focus group, or participate in a clinical trial. There are a variety of ways to give back to the prostate cancer community and advance science. The more we learn about prostate cancer as a disease, the more progress we can make together to improve the lives of men and their families.

Introducing P-PSMA-101: CAR-T for prostate cancer

The P-PSMA-101-001 study is a Phase 1 clinical trial now enrolling patients at multiple locations in the United States. Conducted by Poseida Therapeutics, this study is testing P-PSMA-101, a new immunotherapy called a CAR-T.

P-PSMA-101 is made from your own white blood cells that have been genetically modified in a lab to recognize a protein called PSMA. PSMA is commonly located on the surface of prostate cancer cells and P-PSMA-101 is designed to kill the cancer cell. P-PSMA 101 is given via an intravenous infusion and you may be eligible to receive one or more infusions during the study.

The purpose of this study is to determine if P-PSMA-101 is safe and will help treat patients with metastatic prostate cancer. You may be eligible for the study if you have progressing metastatic, castration resistant prostate cancer; and you have already been treated with a 2nd generation hormone therapy and a chemotherapy called a taxane.

For more information about the P-PSMA-101-001 study including hospitals enrolling patients visit the study registry at: clinicaltrials.gov/ct2/show/NCT04249947 or contact Poseida at (858) 779-3103 or clinicaltrials@poseida.com.

(This content is brought to you by Poseida Therapeutics)

Study

Help Us Understand Appetite Loss and Advanced Cancer

Many people with advanced cancer struggle with low appetite levels and the weight loss that comes with it. That’s why we are researching a study drug — to understand its effect on appetite in people who are experiencing loss of appetite, unintentional weight loss, weakness, and fatigue caused by advanced cancer.
» Learn More
(This content is provided in partnership with Pfizer Inc.)

This edition of the ZEROHour Newsletter supported Bayer.